Allotment of Securities

Date: October 13, 2026 Ref. No.: KDL/SE/056/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400051 Scrip Code: 543328 NSE Symbol: KRSNAA Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Allotment of fully Convertible Warrants on a preferential basis Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with Schedule III to the Listing Regulations (as amended from time to time), and in continuation to our earlier intimation(s) in this regard, we would like to inform you that pursuant to the resolution passed by the Board of Directors (“Board”) at its meeting held on August 13, 2026 and the special resolution passed by the members of the Company through Postal Ballot dated September 17, 2026 and in pursuance of the in-principle approval Letter No. LOD/PREF/PB/FIP/908/2026-27 and letter No. NSE/LIST/56990 dated October 07, 2026 and October 08, 2026 respectively received from the BSE Limited (‘BSE’) and National Stock Exchange of India Limited (‘NSE’) respectively, the Operation Committee vide its resolution dated October 13, 2026, has allotted 16,21,000 (Sixteen Lakhs Twenty-One Thousand Only) fully convertible warrants (“Warrants”) at a price (inclusive of both the Warrant Subscription Price and the Warrant Exercise Price) of ₹ 566/- per warrant (“Warrant Issue Price”) on a preferential basis to Promoter and Promoter Group entity of the Company in the following manner: Name of the Allottee Category Warrant Number of Warrants Subscription Price allotted Received (in INR) Mr. Rajendra Mutha Promoter 1,06,12,500 75,000 Krsna Diagnostics (Mumbai) Promoter Group 21,87,59,000 15,46,000 Private Limited entity The Company has received 25% of the Warrant Issue Price, i.e., ₹ 566/- per warrant, aggregating to ₹ 22,93,71,500/- (Rupees Twenty-Two Crore Ninety- Three Lakh Seventy- One Thousand Five Hundred Only) from the Allottees mentioned above, basis which the Committee has made the allotment of Warrants. The allotment of these Warrants entitles the Allottees to seek conversion of the Warrants in one or more tranches, within a maximum period of 18 months from the date of allotment of the Warrants viz. October 13, 2026, upon payment of 75% (Seventy five per cent) of the Warrant Issue Price, and be allotted one fully paid-up Equity Share of the Company of face value of ₹ 5/- each at a price of ₹ 566/- per share (including premium of ₹ 551/- per share), against each Warrant, with the amount paid against each Warrant be adjusted against the issue price for the resultant Equity Share. The Company has received 25% of the Warrant Issue Price, i.e., ₹ 566/- per warrant, aggregating to ₹ 22,93,71,500/- (Rupees Twenty-Two Crore Ninety- Three Lakh Seventy- One Thousand Five Hundred Only from the Allottees mentioned above, basis which the Committee has made the allotment of Warrants. The allotment of these Warrants entitles the Allottees to seek conversion of the Warrants in one or more tranches, within a maximum period of 18 months from the date of allotment of the Warrants viz. October 13, 2026, upon payment of 75% (Seventy five per cent) of the Warrant Issue Price, and be allotted one fully paid-up Equity Share of the Company of face value of ₹ 5/- each at a price of ₹ 566/- per share (including premium of ₹ 551/- per share), against each Warrant, with the amount paid against each Warrant be adjusted against the issue price for the resultant Equity Share. As the Company has allotted the convertible Warrants to Allottees, there is no change in the paid-up share capital of the Company at this stage. The details required to be disclosed as per Regulation 30 of SEBI Listing Regulations read with SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure-A. You are requested to take the above information on your record. For Krsnaa Diagnostics Limited Sujoy Sudipta Bose Company Secretary and Compliance Officer Annexure-A Sr. Particulars Details 1. Type of securities Warrants proposed to be issued (viz. equity Each Warrant is fully convertible into one fully paid-up equity share of the shares, Company. convertibles etc.) 2. Type of issuance Preferential Issue on a private placement basis, in accordance with the applicable (further public provisions of the Companies Act, 2013 and the rules made thereunder, and Chapter offering, rights issue, V of the SEBI (ICDR) Regulations, 2018 and other applicable law, as amended from depository receipts time to time. (ADR/GDR), qualified institutions placement, preferential allotment etc.) 3. Total number of Allotment of 16,21,000 (Sixteen Lakhs Twenty-One Thousand) Warrants of the securities proposed Company, for cash consideration, at an issue price of ₹ 566/- (Rupees Five Hundred to be issued or the and Sixty Six only) per Warrant, convertible into, 1 (One) fully paid Equity Share of total amount for face value ₹ 5/- each of the Company at a price of ₹ 566/- per share (including which the securities premium of ₹ 551/- per share) for each Warrant (‘Warrant Issue Price’). The amount will be issued paid against Warrant shall be adjusted against the issue price for the resultant (approximately) Equity Shares. An amount equivalent to 25% of the Warrant Issue Price, which was payable at the time of subscription and allotment of each Warrant, has been received by the Company. Upon receipt of the balance 75% of the Warrant Issue Price from the Warrant holder(s), the said Warrants will be converted into equity shares of the Company. The price of the Warrants and the number of Equity Shares to be allotted on conversion Warrants shall be subject to appropriate adjustments as permitted under applicable laws. 4. Name of Investor Mr. Rajendra Mutha Krsna Diagnostics (Mumbai) Private Limited 5. Post allotment of Name Pre-Preferential Allotment *Post-Preferential securities – outcome Allotment of the subscription No. of shares % held No. of shares % held held held Promoter/Promoter Group Category Mr. Rajendra 80,29,920 24.75 81,04,920 23.11 Mutha Krsna 7,65,685 2.36 23,11,685 6.59 Diagnostics (Mumbai) Private Limited Total 87,95,605 27.11 1,04,16,605 29.70 * The % holding calculated in this column is based on the assumption that all the currently outstanding convertible warrants of the company will be fully converted into equity shares. 6. Issue Price/allotted price ₹ 566/- per Warrant. (in case of convertibles) 7. Number of investors 2(two) 8. In case of The rights attached to Warrants may be exercised by the Warrant Holder(s), in one convertibles - or more tranches, at any time on or before the expiry of 18 months, from the date Intimation on of allotment of the Warrants. In the event the Warrant Holder(s) do not exercise conversion of the right attached to the Warrant(s) within 18 months from the date of allotment securities or of the Warrants, such unexercised Warrant(s) shall lapse, and the amount paid to on lapse of the the Company at the time of subscription of such unexercised Warrant(s) shall stand tenure of the forfeited. instrument. 9. Any cancellation or Not Applicable termination of proposal for issuance of securities including reasons thereof.